Search This Blog

Tuesday, February 18, 2020

San Diego County Posts ‘Precautionary’ Emergency Amid Coronavirus Cases

Supervisor Nathan Fletcher announced the city declared a local emergency and a public health emergency. County officials will hold a meeting next week to decide to either extend the declaration or not .
Supervisor Nathan Fletcher announced the city declared a local emergency and a public health emergency to ensure readiness for the county after providing an update on the coronavirus cases in San Diego County Friday afternoon.
“We’re doing this to best position our county to contain and confront the novel coronavirus,” Fletcher said.
Fletcher continued saying that this action does not signify an increase in the risk for the residents of San Diego County.
“By declaring these emergencies, we are better able to provide direction and ensure resources to first responders, hospitals, and members of the local medical community,” Fletcher continued. “We are better to quickly access medical supplies, hospital beds and have access to emergency funds at a local level.”
This update comes after health experts spoke Thursday about the “miscommunication” that led to a coronavirus patient mistakenly being released into the general quarantine at Marine Corps Air Station Miramar, where dozens of U.S. citizens are being held for 14 days.
Nick Yphantides, county chief medical officer for San Diego County said UC San Diego still has seven individuals under their care. Two patients tested positive and five are pending results, all from the MCAS Miramar quarantine.
Out of those people from MCAS Miramar, a 3-year-old girl who was readmitted to the hospital tested negative for the coronavirus, county health officials confirmed on Friday.
Officials had updates and information on the status of patients being treated and the plan for the upcoming week.

The county also said they have seven San Diego County Residents who are persons under investigation for coronavirus. Five have tested negative and two of them are pending results.
Patty Maysent, CEO of UC San Diego Health provided updates on the two patients who tested positive saying one is doing well and the other is in fair condition.
Maysent continued saying patients or visitors at any UC San Diego hospital or clinic should not be worried about seeking medical attention.
“We want to assure the public that you are under no additional exposure risk by visiting any of our hospitals or our clinics, patients should feel confident in making and keeping their appointments,” Maysent said.
During the update, Eric McDonald, Medical Director of Epidemiology & Immunization Services at San Diego County said two individuals under U.S. Immigration and Customs Enforcement (ICE) custody were sent to Sharp Chula Vista Medical Center for evaluation.
“Two individuals in ICE custody were presented to us as possible persons under investigation. We still have test pending for those individuals and they remain under investigation,” McDonald said.
ICE sent NBC 7 the following statement:
At this time, no ICE detainee has tested positive for the 2019 novel coronavirus at the Otay Mesa Detention Center or any other ICE facility. 
Out of the abundance of caution,  ICE is taking all necessary precautionary measures to ensure all ICE detainees are screened medically at their arrival to our facilities. Medical professionals at ICE detention facilities medically screen all new ICE detainees within 24 hours of their arrival to ensure that contagious diseases are not spread throughout the facility, and elsewhere. As an additional measure of defense, ICE detainees suspected of exposure or infection of certain diseases are medically “cohorted,” in line with CDC guidelines and ICE detention standards.”
The county said those two patients are unlikely to test positive.

In summary, as of Feb. 14, the county said:
There are seven San Diego County residents “persons under investigation”:
  • 5 tested negative
  • 2 are pending results
There are four non-residents located in the county:
  • 2 tested negative
  • 2 are pending results
There are 171 individuals that returned from China with no symptoms (low risk). At least 20 to 30 individuals are referred to each day to the CDC:
  • 48 cleared self-quarantined requirement time
  • 123 are still under monitoring (at home)
  • No individual has become a person under investigation
There are 13 San Diego residents who did not visit China but were next to people who were later confirmed coronavirus patients in the U.S.
  • 8 of those people were cleared
  • 4 are still being monitored
  • 1 became a person under investigation but later tested negative for coronavirus
Patients part of the MCAS Miramar quarantine:
  • There are 7 persons under investigation and staying at UC San Diego Medical Center
  • 2 of those tested positive
  • 4 are pending test results
  • 1 tested negative– a 3-year-old tested at Rady Children’s Hospital
ICE Custody:
  • 2 people in ICE custody were brought to Sharp Chula Vista they were evaluated and returned to ICE facilities in isolation.

The next meeting to further discuss the declaration will be held on Wednesday, Feb. 19 and officials will decide whether or not to extend the declaration for 30 days, Fletcher said.

WuXi Biologics up 3% on vaccine production deal

Ultra-thinly traded WuXi Biologics (OTCPK:WXXWY +3%) is up, albeit on a scant 1,479 shares, on the heels of its announcement that WuXi Vaccines, its joint venture with Shanghai Hile Bio-technology, has inked a 20-year vaccine manufacturing agreement with an unnamed global vaccine leader valued at ~$3B.
Under the terms of the deal, WuXi Vaccines will build a dedicated production facility that, it says, should be on line in 2022.

Senseonics up on new coverage of Eversense

Senseonics Holdings (NYSEMKT:SENS) perks up 6% premarket on modest volume in reaction to its announcement that Cigna is now covering its Eversense CGM System (effective 2/15).

Passage Bio sets IPO terms

Gene therapy developer Passage Bio (PASG) has filed a prospectus for its IPO of 7.4M common shares at $16 – 18.

FDA OKs new dosage form of Horizon’s Procysbi

The FDA approves Horizon Therapeutics’ (HZNP -0.7%) Procysbi (cysteamine bitartrate) in tear-open packets for nephropathic cystinosis patients as young as one year old.
The cystine-depleting agent is also available in 25 mg and 75 mg capsules.

Bellerophon up on positive INOpulse data

Thinly traded nano cap Bellerophon Therapeutics (NASDAQ:BLPH) jumps 61% premarket on robust volume in reaction to positive topline data from a 16-subject Phase 2 clinical trial, PULSE-PHPF-002, evaluating INOpulse in patients with pulmonary hypertension associated with pulmonary fibrosis.
Acute treatment with INOpulse reduced pulmonary vascular resistance (PVR) by 21% with increased benefit on dose escalation, a primary endpoint.
Mean pulmonary arterial pressure (PAP), another primary endpoint, dropped 12%.
No new safety signals were observed.
A Phase 3 trial is next up.
INOpulse is a drug-device combination system that delivers pulsed doses of nitric oxide.

Jaguar Land Rover UK output threatened by coronavirus-linked parts shortage

Jaguar Land Rover has enough parts from China to maintain its British production for the next two weeks but not beyond that at the moment due to the impact of the coronavirus outbreak, the firm’s boss said on Tuesday.

Britain’s biggest carmaker, which operates three car factories in its home market, joined major global companies such as Apple in warning of the impact of the virus on supply chains.
The rapidly spreading virus has killed nearly 1,900 in China and stricken some 72,000 people, confining millions to their homes, disrupting supply chains and delaying reopening of factories after the extended Lunar New Year holiday break.
“We are safe for this week and we are safe for next week and in the third week we have … parts missing,” said Chief Executive Ralf Speth.
“We have flown parts in suitcases from China to the UK.”
He said the firm’s Chinese factory would open next week and was “safe for the very first week.”
Sales were not currently happening in China and it was unclear when they would return, he added.
The boss of Tata Motors, JLR’s parent company, speaking at the same event, said the company does not have sufficient visibility regarding parts suppliers from China.
“We are safe for the month of February and for a good part of March,” said Guenter Butschek. “Are we fully covered at this point of time for the full month of March? Unfortunately … not.”